Mass General Brigham Jan 25 2025 Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients. The research is published in  Science Advances .​​​​​​​ “During the early days of the pandemic, we wanted to see if our approach for

Tag-uri: Coronavirus